|
|
| |
 Brief Description |
| |
| This presentation at the APSARD Symposium in Philadelphia 2009 discusses pharmacogenetics and pharmacogenomics as related to ADHD. Eli Lilly and Shire sponsored the filming, broadcast and archiving of the content of this symposium. MediCom offered continuing medical education with this content.
|
| |
Full Description |
| |
|
| |
Citation |
| |
|
| |
Abstract |
| |
|
| |
Introduction |
| |
|
| |
Results |
|
|
|
Discussions |
| |
|
| |
Material Methods |
| |
|
| |
References |
| |
| Gruber R, Joober R, Grizenko N, Leventhal BL, Cook EH Jr, Stein MA. Dopamine transporter genotype and stimulant side effect factors in youth diagnosed with attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2009 Jun;19(3):233-9.
Stein MA, McGough JJ. The pharmacogenomic era: promise for personalizing attention deficit hyperactivity disorder therapy. Child Adolesc Psychiatr Clin N Am. 2008 Apr;17(2):475-90, |
| |
|
|
|
Stats |
| |
| Publish date |
Views |
Ref# |
| Jan 03, 2010 |
460 |
VA:11:15:2134:2009 |
|
| |
Rating |
|
|
|
|
|
Embed Code
|
|
|
| |
Files |
| |
|
| |
| |
|
